All In Biotech

Drug Trial Radar · NCT07837973

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

A Double-Blind, Randomized, Multi-Center, Dose-Ranging, Phase 2 Study of the Efficacy and Safety of ALV-100 Versus Placebo for Maintenance of Weight Loss in Patients Previously Treated With Incretin-Based Therapies

Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 220 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

220

Planned (sponsor's estimate)

Start

Aug 10, 2026

Primary completion

Aug 24, 2027

Study completion Aug 24, 2027

Sponsor

Lead sponsor
Alveus Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study of ALV-100 to assess efficacy, safety and tolerability among participants with overweight or obesity who have previously achieved a body weight reduction of ≥10% while treated with incretin-based therapies.

Conditions

  • Overweight , Obesity
  • Adults

Interventions

  • ALV-100Drug

    Experimental drug

  • PlaceboDrug

    Volume matched placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Dose response of ALV-100 as assessed by maintenance of weight lossTime frame: 24 weeks

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama - Birmingham

    Birmingham, Alabama · Recruiting

  • DM Clinical Research

    Sun City, Arizona · Recruiting

  • AMR Clinical

    Tempe, Arizona · Recruiting

  • Profound Research

    Oceanside, California · Recruiting

  • DM Clinical Research

    Bradenton, Florida · Recruiting

  • DM Clinical Research

    Doral, Florida · Recruiting

  • Clinical Neuroscience Solutions

    Orlando, Florida · Recruiting

  • North Georgia Clinical Research

    Woodstock, Georgia · Recruiting

  • Christie Clinic

    Champaign, Illinois · Recruiting

  • BRCR Global Louisiana

    Gretna, Louisiana · Recruiting

  • Profound Research

    Farmington Hills, Michigan · Recruiting

  • ALSA Research-Manhattan

    New York, New York · Recruiting

  • TMA Headlands

    Wilmington, North Carolina · Recruiting

  • Lynn Health Science Institute

    Oklahoma City, Oklahoma · Recruiting

  • AMR Clinical

    Nashville, Tennessee · Recruiting

  • DM Clinical Research

    Irving, Texas · Recruiting

  • DM Clinical Research - Dominion Family Healthcare

    San Antonio, Texas · Recruiting

  • Tekton Research

    San Antonio, Texas · Recruiting

  • DM Clinical Research

    Tomball, Texas · Recruiting

  • AMR Clinical

    South Jordan, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.